0.1053 USD
-0.02 (-17.8%)
0.12 USD
+0.01 (+13.96%)
ChartMill assigns a Buy % Consensus number of 83% to NMRD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.67. This target is 8133.62% above the current price.
NMRD was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NMRD.
In the previous month the buy percentage consensus was at a similar level.
NMRD was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-17 | EF Hutton | Maintains | Buy -> Buy |
| 2023-03-30 | EF Hutton | Reiterate | Buy |
| 2023-02-28 | EF Hutton | Maintains | Buy |
| 2023-02-27 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-19 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-02 | EF Hutton | Initiate | Buy |
NEMAURA MEDICAL INC / NMRD FAQ
What do analysts expect the price target to be for NEMAURA MEDICAL INC (NMRD)?
7 analysts have analysed NMRD and the average price target is 8.67 USD. This implies a price increase of 8133.62% is expected in the next year compared to the current price of 0.1053.
Can you provide the consensus rating for NEMAURA MEDICAL INC stock?
The consensus rating for NEMAURA MEDICAL INC (NMRD) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover NEMAURA MEDICAL INC (NMRD) stock?
The number of analysts covering NEMAURA MEDICAL INC (NMRD) is 7.